Literature DB >> 10918394

Complex germline rearrangement of BRCA1 associated with breast and ovarian cancer.

S R Payne1, B Newman, M C King.   

Abstract

Germline mutations in BRCA1 predispose to breast and ovarian cancer. Most germline BRCA1 mutations are small insertions, deletions, or single base pair (bp) substitutions. These mutation classes are rarely found as somatic mutations in BRCA1. On the other hand, somatic deletions of multiple mega-base pairs (Mb) including BRCA1, as reflected by loss of heterozygosity, occur frequently in both inherited and sporadic breast and ovarian cancers. To determine whether deletions or rearrangements of hundreds to thousands of bps might contribute to inherited mutation in BRCA1, we developed a Long PCR strategy for screening the entire genomic BRCA1 locus in high-risk families. We evaluated genomic DNA from one high-risk family of European ancestry with BRCA1-linked cancer in which no genomic mutations had been detected using conventional methods. Long PCR revealed a complex mutation, g.12977 ins10 del1039 (based on GenBank L78833), comprising an inverted duplication and deletion in BRCA1 that removes portions of exon 3 and intron 3, including the 5' splice site for intron 3. As a result of the deletion, exon 3 is skipped, leading to a truncated protein and disease predisposition. Unlike previously reported large germline deletions in BRCA1, neither breakpoint resides within an Alu element. The g.12977 ins10 del1039 mutation was not detected among 11 other breast cancer families, nor among 406 breast cancer patients unselected for family history. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918394     DOI: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1008>3.0.co;2-f

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  7 in total

1.  Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot.

Authors:  Nadine Puget; Sophie Gad; Laure Perrin-Vidoz; Olga M Sinilnikova; Dominique Stoppa-Lyonnet; Gilbert M Lenoir; Sylvie Mazoyer
Journal:  Am J Hum Genet       Date:  2002-03-05       Impact factor: 11.025

2.  The BRCA1 exon 13 duplication in the Swedish population.

Authors:  Barbara Kremeyer; Maria Soller; Kristina Lagerstedt; Paula Maguire; Sylvie Mazoyer; Margareta Nordling; Jan Wahlström; Annika Lindblom
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

3.  Accuracy of MSI testing in predicting germline mutations of MSH2 and MLH1: a case study in Bayesian meta-analysis of diagnostic tests without a gold standard.

Authors:  Sining Chen; Patrice Watson; Giovanni Parmigiani
Journal:  Biostatistics       Date:  2005-04-14       Impact factor: 5.899

4.  Inherited BRCA2 mutations in African Americans with breast and/or ovarian cancer: a study of familial and early onset cases.

Authors:  Yasmine Kanaan; Elikem Kpenu; Kim Utley; Lucile Adams-Campbell; Georgia M Dunston; Lawrence C Brody; Carolyn Broome
Journal:  Hum Genet       Date:  2003-08-26       Impact factor: 4.132

5.  A de novo complete BRCA1 gene deletion identified in a Spanish woman with early bilateral breast cancer.

Authors:  Zaida Garcia-Casado; Ignacio Romero; Antonio Fernandez-Serra; Luis Rubio; Francisco Llopis; Ana Garcia; Pilar Llombart; Jose A Lopez-Guerrero
Journal:  BMC Med Genet       Date:  2011-10-11       Impact factor: 2.103

6.  High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic.

Authors:  Petra Vasickova; Eva Machackova; Miroslava Lukesova; Jiri Damborsky; Ondrej Horky; Hana Pavlu; Jitka Kuklova; Veronika Kosinova; Marie Navratilova; Lenka Foretova
Journal:  BMC Med Genet       Date:  2007-06-11       Impact factor: 2.103

7.  Screening for germline BRCA1, BRCA2, TP53 and CHEK2 mutations in families at-risk for hereditary breast cancer identified in a population-based study from Southern Brazil.

Authors:  Edenir Inêz Palmero; Bárbara Alemar; Lavínia Schüler-Faccini; Pierre Hainaut; Carlos Alberto Moreira-Filho; Ingrid Petroni Ewald; Patricia Koehler Dos Santos; Patricia Lisbôa Izetti Ribeiro; Cristina Brinkmann de Netto Oliveira; Florence Le Calvez-Kelm; Sean Tavtigian; Silvia Liliana Cossio; Roberto Giugliani; Maira Caleffi; Patricia Ashton-Prolla
Journal:  Genet Mol Biol       Date:  2016-05-24       Impact factor: 1.771

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.